Skip Navigation


Brain Advance Access originally published online on July 20, 2005
Brain 2005 128(9):1996-2005; doi:10.1093/brain/awh598
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
128/9/1996    most recent
awh598v2
awh598v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (80)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kertesz, A.
Right arrow Articles by Munoz, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kertesz, A.
Right arrow Articles by Munoz, D. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

The evolution and pathology of frontotemporal dementia

Andrew Kertesz1, Paul McMonagle1, Mervin Blair1, Wilda Davidson1 and David G. Munoz2,3

1 Department of Cognitive Neurology, St Joseph's Hospital, London, Ontario and 2 Department of Pathology, University of Western Ontario, Canada 3 Present address: David G. Munoz, St Michael's Hospital, Toronto, Ontario, Canada

Correspondence to: Dr Andrew Kertesz, Department of Cognitive Neurology, St Joseph's Hospital, London, Ontario N6A 4V2, Canada E-mail: Andrew.Kertesz{at}sjhc.london.on.ca

This is a clinicopathologic study of a prospective, clinic-based cohort of patients with frontotemporal dementia (FTD)/Pick complex, who were followed to autopsy. A total of 60 patients with the clinical syndromes of the behavioural variant of FTD (FTD-bv) (n = 32), primary progressive aphasia (PPA) (n = 22), corticobasal degeneration syndrome (CBDS) (n = 4) and progressive supranuclear palsy (PSP) (n = 2) at onset, referred to a cognitive neurology clinic who had subsequent post-mortem examination were included. The most common histological variety was motor neurone disease type inclusion (MNDI) (n = 18), followed by corticobasal degeneration (CBD) (n = 12), then Pick's disease (n = 6), dementia lacking distinctive histology (DLDH) (n = 6) and PSP (n = 3). Others fulfilled the histological criteria for Alzheimer's disease combined with glial pathology (n = 6), Alzheimer's disease only (n = 4), Lewy body variant (n = 2), prion disease (n = 1), vascular dementia (n = 1) and undetermined (n = 1). The most common first syndrome among the MNDI and DLDH (tau negative) pathologies was FTD-bv, but subsequently progressive aphasia (PA), occasionally CBDS and semantic dementia also developed. Tau positive histologies of CBD, PSP and Pick bodies were most frequently associated with PPA onset or CBDS/PSP, but behavioural symptoms were also common. Age of onset was earlier in tau negative cases, but the duration of illness and gender distribution were about the same in all histological variants. Although the tau negative and positive histologies are predicted to some extent by the clinical onset, the extent of the overlap and the convergence of the syndromes in the course of the disease argue in favour of maintaining the clinical and pathological varieties under a single umbrella.

Key Words: frontotemporal dementia; primary progressive aphasia; corticobasal degeneration; progressive supranuclear palsy; Pick's disease

Abbreviations: CBD = corticobasal degeneration (pathology); CBDS = corticobasal degeneration syndrome (clinical); DLDH = dementia lacking distinctive histology; FTD = frontotemporal dementia; FTD-bv = behavioural variant of frontotemporal dementia; FTLD = frontotemporal lobar degeneration; MND = motor neuron disease; MNDI = motor neuron disease type inclusions; PA = progressive aphasia (secondary); PPA = primary progressive aphasia; PSP = progressive supranuclear palsy; SD = semantic dementia

Received December 18, 2004. Revised June 16, 2005. Accepted June 17, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
M. Grossman, S. X. Xie, D. J. Libon, X. Wang, L. Massimo, P. Moore, L. Vesely, R. Berkowitz, A. Chatterjee, H. B. Coslett, et al.
Longitudinal decline in autopsy-defined frontotemporal lobar degeneration
Neurology, May 27, 2008; 70(22): 2036 - 2045.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Bian, J. C. Van Swieten, S. Leight, L. Massimo, E. Wood, M. Forman, P. Moore, I. de Koning, C. M. Clark, S. Rosso, et al.
CSF biomarkers in frontotemporal lobar degeneration with known pathology
Neurology, May 6, 2008; 70(19_Part_2): 1827 - 1835.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
I. Le Ber, A. Camuzat, D. Hannequin, F. Pasquier, E. Guedj, A. Rovelet-Lecrux, V. Hahn-Barma, J. van der Zee, F. Clot, S. Bakchine, et al.
Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study
Brain, March 1, 2008; 131(3): 732 - 746.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S X Xie, M S Forman, J Farmer, P Moore, Y Wang, X Wang, C M Clark, H B Coslett, A Chatterjee, S E Arnold, et al.
Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 126 - 129.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. van der Zee, H. Urwin, S. Engelborghs, M. Bruyland, R. Vandenberghe, B. Dermaut, T. De Pooter, K. Peeters, P. Santens, P. P. De Deyn, et al.
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro
Hum. Mol. Genet., January 15, 2008; 17(2): 313 - 322.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
G.D. Rabinovici, W.W. Seeley, E.J. Kim, M.L. Gorno-Tempini, K. Rascovsky, T.A. Pagliaro, S.C. Allison, C. Halabi, J.H. Kramer, J.K. Johnson, et al.
Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2008; 22(6): 474 - 488.
[Abstract] [PDF]


Home page
NeurologyHome page
K. A. Josephs, J. L. Whitwell, J. R. Duffy, W. A. Vanvoorst, E. A. Strand, W. T. Hu, B. F. Boeve, N. R. Graff-Radford, J. E. Parisi, D. S. Knopman, et al.
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology
Neurology, January 1, 2008; 70(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E J Kim, G D Rabinovici, W W Seeley, C Halabi, H Shu, M W Weiner, S J DeArmond, J Q Trojanowski, M L Gorno-Tempini, B L Miller, et al.
Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration
J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1375 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Grossman, D. J. Libon, M. S. Forman, L. Massimo, E. Wood, P. Moore, C. Anderson, J. Farmer, A. Chatterjee, C. M. Clark, et al.
Distinct Antemortem Profiles in Patients With Pathologically Defined Frontotemporal Dementia
Arch Neurol, November 1, 2007; 64(11): 1601 - 1609.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. T. Hu, J. N. Mandrekar, J. E. Parisi, D. S. Knopman, B. F. Boeve, R. C. Petersen, M. Hutton, D. W. Dickson, and K. A. Josephs
Clinical Features of Pathologic Subtypes of Behavioral-Variant Frontotemporal Dementia
Arch Neurol, November 1, 2007; 64(11): 1611 - 1616.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. M. Laws, R. Perneczky, A. Drzezga, J. Diehl-Schmid, B. Ibach, J. Bauml, T. Eisele, H. Forstl, A. Kurz, and M. Riemenschneider
Association of the Tau Haplotype H2 With Age at Onset and Functional Alterations of Glucose Utilization in Frontotemporal Dementia
Am J Psychiatry, October 1, 2007; 164(10): 1577 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Grossman, E. M. Wood, P. Moore, M. Neumann, L. Kwong, M. S. Forman, C. M. Clark, L. F. McCluskey, B. L. Miller, V. M.-Y. Lee, et al.
TDP-43 Pathologic Lesions and Clinical Phenotype in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions
Arch Neurol, October 1, 2007; 64(10): 1449 - 1454.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
D. G. Munoz, R. Ros, M. Fatas, F. Bermejo, and J. G. de Yebenes
Progressive Nonfluent Aphasia Associated With a New Mutation V363I in Tau Gene
American Journal of Alzheimer's Disease and Other Dementias, September 1, 2007; 22(4): 294 - 299.
[Abstract] [PDF]


Home page
Arch NeurolHome page
V. M. Van Deerlin, E. M. Wood, P. Moore, W. Yuan, M. S. Forman, C. M. Clark, M. Neumann, L. K. Kwong, J. Q. Trojanowski, V. M.-Y. Lee, et al.
Clinical, Genetic, and Pathologic Characteristics of Patients With Frontotemporal Dementia and Progranulin Mutations
Arch Neurol, August 1, 2007; 64(8): 1148 - 1153.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. D. Rabinovici, A. J. Furst, J. P. O'Neil, C. A. Racine, E. C. Mormino, S. L. Baker, S. Chetty, P. Patel, T. A. Pagliaro, W. E. Klunk, et al.
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Neurology, April 10, 2007; 68(15): 1205 - 1212.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. L. Whitwell, C. R. Jack Jr, J. E. Parisi, D. S. Knopman, B. F. Boeve, R. C. Petersen, T. J. Ferman, D. W. Dickson, and K. A. Josephs
Rates of cerebral atrophy differ in different degenerative pathologies
Brain, April 1, 2007; 130(4): 1148 - 1158.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. J. Nestor, K. Balan, H. K. Cheow, T. D. Fryer, J. A. Knibb, J. H. Xuereb, and J. R. Hodges
Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia
Neurology, January 16, 2007; 68(3): 238 - 239.
[Full Text] [PDF]


Home page
BrainHome page
I. L. Ber, E. Guedj, A. Gabelle, P. Verpillat, M. Volteau, C. Thomas-Anterion, M. Decousus, D. Hannequin, P. Vera, L. Lacomblez, et al.
Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.
Brain, November 1, 2006; 129(Pt 11): 3051 - 3065.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Masellis, P. Momeni, W. Meschino, R. Heffner Jr, J. Elder, C. Sato, Y. Liang, P. S. George-Hyslop, J. Hardy, J. Bilbao, et al.
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome
Brain, November 1, 2006; 129(11): 3115 - 3123.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. McMonagle, M. Blair, and A. Kertesz
Corticobasal degeneration and progressive aphasia
Neurology, October 24, 2006; 67(8): 1444 - 1451.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. A. Josephs, J. R. Duffy, E. A. Strand, J. L. Whitwell, K. F. Layton, J. E. Parisi, M. F. Hauser, R. J. Witte, B. F. Boeve, D. S. Knopman, et al.
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech
Brain, June 1, 2006; 129(6): 1385 - 1398.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Kertesz, D. P. Salmon, D. Galasko, and K. Rascovsky
Rate of progression differs in frontotemporal dementia and Alzheimer disease
Neurology, May 23, 2006; 66(10): 1607 - 1607.
[Full Text] [PDF]


Home page
BrainHome page
D. G. Munoz, T. Del Ser, and J. Woulfe
Semantic dementia: linking loss of brain and brawn
Brain, September 1, 2005; 128(9): 1962 - 1963.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.